[Advances of hemophilia A treatment]

[Article in Chinese]

Affiliations

¹ State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

[Article in Chinese]

W Zhang et al. Zhonghua Xue Ye Xue Za Zhi. 2018.

. 2018 Jan 14;39(1):83-86.

doi: 10.3760/cma.j.issn.0253-2727.2018.01.023.

¹ State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

No abstract available

References

1. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia[J] Haemophilia. 2013;19(1):e1–47. doi: 10.1111/j.1365-2516.2012.02909.x. - DOI - PubMed
1. Mannucci PM, Tuddenham EG. The hemophilias—from royal genes to gene therapy[J] N Engl J Med. 2001;344(23):1773–1779. doi: 10.1056/nejm200106073442307. - DOI - PubMed
1. 中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 血友病诊断与治疗中国专家共识(2017年版)[J] 中华血液学杂志. 2017;38(5):364–370. doi: 10.3760/cma.j.issn.0253-2727.2017.05.002. - DOI
1. Wyseure T, Mosnier LO, von Drygalski A. Advances and challenges in hemophilic arthropathy[J] Semin Hematol. 2016;53(1):10–19. doi: 10.1053/j.seminhematol.2015.10.005. - DOI - PMC - PubMed
1. Laffan M. New products for the treatment of haemophilia[J] Br J Haematol. 2016;172(1):23–31. doi: 10.1111/bjh.13797. - DOI - PubMed